Evidence map›Paper›PMID 38939642›Full record

ArticleJACC. Advances2024

Risk Factors for Death or Transplant After Stage 2 Palliation for Single Ventricle Heart Disease.

Emily M Bucholz, Minmin Lu, Lynn Sleeper, Jeffrey Vergales, Michael A Bingler, Christina Ronai, Jeffrey B Anderson, Katherine E Bates, Carole Lannon, Lindsey Reynolds and 1 more

Abstract read
In one paragraph

Article in JACC. Advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emily M BucholzSection of Cardiology, Department of Pediatrics, Children's Hospital of Colorado and the University of Colorado School of Medicine, Denver, Colorado, USA.
Minmin LuDepartment of Cardiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Lynn SleeperDepartment of Cardiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Jeffrey VergalesDivision of Pediatric Cardiology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Michael A BinglerNational Pediatric Cardiology Quality Improvement Collaborative.
Christina RonaiDepartment of Cardiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
Jeffrey B AndersonThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Katherine E BatesCongenital Heart Center, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
Carole LannonCongenital Heart Center, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
Lindsey ReynoldsDepartment of Cardiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
David W BrownDepartment of Cardiology, Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: For infants with single ventricle heart disease, the time after stage 2 procedure (S2P) is believed to be a lower risk period compared with the interstage period; however, significant morbidity and mortality still occur. Objectives: This study aimed to identify risk factors for mortality or transplantation referral between S2P surgery and the first birthday. Methods: Retrospective cohort analysis of infants in the National Pediatric Cardiology Quality Improvement Collaborative who underwent staged single ventricle palliation from 2016 to 2022 and survived to S2P. Multivariable logistic regression and classification and regression trees were performed to identify risk factors for mortality and transplantation referral after S2P. Results: Of the 1,455 patients in the cohort who survived to S2P, 5.2% died and 2.3% were referred for transplant. Overall event rates at 30 and 100 days after S2P were 2% and 5%, respectively. Independent risk factors for mortality and transplantation referral included the presence of a known genetic syndrome, shunt type at stage 1 procedure (S1P), tricuspid valve repair at S1P, longer time to extubation and reintubation after S1P, ≥ moderate tricuspid regurgitation prior to S2P, younger age at S2P, and the risk groups identified in the classification and regression tree analysis (extracorporeal membrane oxygenation after S1P and longer S2P cardiopulmonary bypass time without extracorporeal membrane oxygenation). Conclusions: Mortality and transplantation referral rates after S2P to 1 year of age remain high ∼7%. Many of the identified risk factors after S2P are similar to those established for interstage factors around the S1P, whereas others may be unique to the period after S2P.

Indexed as

Glenn palliationhypoplastic left heart syndromeoutcome predictionsingle ventricle heart disease

Identifiers

PMID38939642
PMCPMC11198479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.